Clinical Trial Update: Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and potential efficacy of placental-derived exosomes and umbilical cord mesenchymal stem cells in moderate-to-severe COVID-19–as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Placental-derived exosomes
• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Vitti Labs, LLC | Conditions: COVID-19 Acute Respiratory Distress Syndrome, Respiratory Distress Syndrome | Phase 1 | Status: SUSPENDED